Our Molecular services deliver cutting-edge techniques for genomic and biomarker analysis, supporting translational research and clinical development. We provide accurate, high-throughput solutions for complex molecular studies.
• qPCR and ddPCR for gene expression and viral load quantification
• Next-Generation Sequencing (NGS) for genomic and microbiome analysis
• Multi-pathogen screening platforms
• Molecular profiling for biomarkers
Accelerate therapeutic development with our advanced QX700™ S ddPCR technology. Fully automated, scalable workflows for rapid, accurate molecular analysis in preclinical or clinical samples. With dynamic loading, flexibility and increased capacity we can scale when your trial demands change. Multiplex with up to 7 markers on one slide.
Precise target quantification, via hLAB’s real-time quantitative PCR (RT-qPCR) for use in either preclinical or clinical samples. For example, this technique can be used to provide critical data on viral load with high accuracy and reliability. Similarly, this technique can be applied to any host or pathogen genomes.
We offer cutting-edge multi pathogen qualitative screening platforms that enable the rapid and accurate detection of various pathogens from a single sample. Our high-throughput systems, powered by two industry-leading technologies (GenMark® ePlex® & BioFire®) with full pathogen panels, ensure efficient processing and reliable results, making it ideal for clinical diagnostics, research, and public health applications.
• Biomarker discovery and validation, pre–clinical Biodistribution, GLP
• NGS genotyping, variant analysis, whole genome sequencing
• Diagnostics development
• Translational research programs
• Vaccine development
• Phase I-III Clinical Trials
• High sensitivity and specificity
• Automated workflows for reproducibility
• Regulatory-compliant molecular assays
• In house expertise
Sign up to our emails and follow us on social media to keep up to date with hVIVO.
